Research Article

Efficacy of Surgery in Patients with Stage I Primary Parotid Gland Lymphoma: A Population-Based Study

Table 5

Univariate and multivariate analysis of cancer-specific survival.

CharacteristicsUnivariate analysis HR (95% CI)Multivariate analysis HR (95% CI)

Age
 ≤651
 >653.475 (2.323–5.198)<0.0013.634 (2.389–5.528)<0.001
Sex
 Female1
 Male1.126 (0.772–1.641)0.538NANA
Race
 White1
 Black1.040 (0.557–1.940)0.902NANA
 Other0.343 (0.109–1.083)0.068NANA
Marital status
 No married1
 Married0.549 (0.378–0.795)0.0020.663 (0.453–0.971)0.035
Laterality
 Right1
 Left1.432 (0.976–2.099)0.066NANA
 Bilateral1.764 (0.547–5.688)0.342NANA
Histology
 MALT1
 DLBCL4.045 (2.413–6.783)<0.0013.471 (2.036–5.917)<0.001
 FL1.973 (1.131–3.442)0.0171.665 (0.951–2.916)0.074
 Other3.630 (2.166–6.083)<0.0013.513 (2.061–5.989)<0.001
Year of diagnosis
 1998–20031
 2004–20090.746 (0.493–1.128)0.1650.827 (0.542–1.262)0.401
 2010–20150.410 (0.218–0.772)0.0060.397 (0.209–0.753)0.005
Methods
 No surgery1
 Local tumor excision0.727 (0.420–1.258)0.2550.935 (0.53–1.647)0.815
 Superficial parotidectomy0.717 (0.436–1.179)0.1900.840 (0.506–1.395)0.502
 Total parotidectomy0.429 (0.258–0.715)0.0010.573 (0.339–0.968)0.037
Radiation
 No1
 Yes0.663 (0.454–0.969)0.0340.607 (0.410–0.898)0.012
Chemotherapy
 No1
 Yes1.287 (0.876–1.891)0.198NANA